Deciphering the mitophagy receptor network identifies a crucial role for OPTN (optineurin) in acute myeloid leukemia

References

• Vetrie D, Helgason GV, Copland M. The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML. Nat Rev Cancer. 2020;20(3):158–173. doi: 10.1038/s41568-019-0230-9 InternetAvailable from.
   PubMed Web of Science ®Google Scholar
• Hackl H, Astanina K, Wieser R. Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia. J Hematol Oncol. 2017;10(1):1–16. doi: 10.1186/s13045-017-0416-0
   PubMedGoogle Scholar
• Dykstra KM, Fay HRS, Massey AC, et al. Inhibiting autophagy targets human leukemic stem cells and hypoxic AML blasts by disrupting mitochondrial homeostasis. Blood Adv. 2021;5(8):2087–2100. doi: 10.1182/bloodadvances.2020002666
   PubMed Web of Science ®Google Scholar
• Pérez-Hernández M, Arias A, Martínez-García D, et al. Targeting autophagy for cancer treatment and tumor chemosensitization. Cancers. 2019;11(10):11. doi: 10.3390/cancers11101599
   Web of Science ®Google Scholar
• Folkerts H, Hilgendorf S, Wierenga ATJ, et al. Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia. Cell Death Dis. 2017;8(7):e2927–e2927. InternetAvailable from. doi: 10.1038/cddis.2017.317
   PubMedGoogle Scholar
• Koschade SE, Klann K, Shaid S, et al. Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia. Leukemia. 2022;36(10):2396–2407. doi: 10.1038/s41375-022-01678-y
   PubMed Web of Science ®Google Scholar
• Rangwala R, Leone R, Chang YC, et al. Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. Autophagy. 2014;10(8):1369–1379. doi: 10.4161/auto.29118
   PubMed Web of Science ®Google Scholar
• Pei S, Minhajuddin M, Adane B, et al. AMPK/FIS1-mediated mitophagy is required for self-renewal of human AML stem cells. Cell Stem Cell. 2018;23(1):86–100.e6. InternetAvailable from. doi: 10.1016/j.stem.2018.05.021
   PubMed Web of Science ®Google Scholar
• Koschade SE, Brandts CH. Selective autophagy in normal and malignant hematopoiesis. J Mol Biol. 2019;432(1):261–282. doi: 10.1016/j.jmb.2019.06.025 InternetAvailable from.
   PubMed Web of Science ®Google Scholar
• Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Cell Biol. 2011;12(1):9–14. doi: 10.1038/nrm3028 InternetAvailable from.
   PubMed Web of Science ®Google Scholar
• Villa E, Marchetti S, Ricci JE. No Parkin zone: mitophagy without Parkin. Trends Cell Biol. 2018;28:882–895. InternetAvailable from. doi: 10.1016/j.tcb.2018.07.004
   PubMed Web of Science ®Google Scholar
• Nguyen TD, Shaid S, Vakhrusheva O, et al. Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy. Blood. 2019;133(2):168–179. doi: 10.1182/blood-2018-02-833475
   PubMed Web of Science ®Google Scholar
• Zellner S, Schifferer M, Behrends C. Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling. Mol Cell. 2021;81(6):1337–1354.e8. doi: 10.1016/j.molcel.2021.01.009 InternetAvailable from.
   PubMed Web of Science ®Google Scholar
• Lazarou M, Sliter DA, Kane LA, et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;524(7565):309–314. doi: 10.1038/nature14893
   PubMed Web of Science ®Google Scholar
• Ajoolabady A, Aslkhodapasandhokmabad H, Aghanejad A, et al. Mitophagy receptors and mediators: therapeutic targets in the management of cardiovascular ageing. Ageing Res Rev [InternetAvailable from]. 2020;62:101129. doi: 10.1016/j.arr.2020.101129
   PubMed Web of Science ®Google Scholar
• Mancias JD, Wang X, Gygi SP, et al. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature. 2014;509(7498):105–109. doi: 10.1038/nature13148
   PubMed Web of Science ®Google Scholar
• Katayama H, Kogure T, Mizushima N, et al. A sensitive and quantitative technique for detecting autophagic events based on lysosomal delivery. Chem Biol [InternetAvailable from]. 2011;18:1042–1052. doi: 10.1016/j.chembiol.2011.05.013
   PubMed Web of Science ®Google Scholar
• Vives-Bauza C, Zhou C, Huang Y, et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A. 2010;107(1):378–383. doi: 10.1073/pnas.0911187107
   PubMed Web of Science ®Google Scholar
• Allen GFG, Toth R, James J, et al. Loss of iron triggers PINK1/Parkin-independent mitophagy. EMBO Rep. 2013;14(12):1127–1135. InternetAvailable from. doi: 10.1038/embor.2013.168
   PubMed Web of Science ®Google Scholar
• Dempster J, Rossen J, Kazachkova M, et al. Extracting biological insights from the project achilles genome-scale CRISPR screens in cancer cell lines. bioRxiv. 2019. doi: 10.1101/720243.
   Google Scholar
• Mani R, St. Onge RP, Hartman IJ, et al. Defining genetic interaction. Proc Natl Acad Sci U S A. 2008;105(9):3461–3466. doi: 10.1073/pnas.0712255105
   PubMed Web of Science ®Google Scholar
• Diehl V, Wegner M, Grumati P, et al. Minimized combinatorial CRISPR screens identify genetic interactions in autophagy. Nucleic Acids Res. 2021;49(10):5684–5704. InternetAvailable from: https://academic.oup.com/nar/article/49/10/5684/6270805
   PubMed Web of Science ®Google Scholar
• Tsai WH. Moment-preserving thresolding: a new approach. Comput Vision, Graph Image Process. 1985;29(3):377–393. doi: 10.1016/0734-189X(85)90133-1
   Google Scholar
• Wild P, Farhan H, McEwan DG, et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science. 2011;333(6039):228–233. InternetAvailable from: doi: 10.1016/0734-189X(85)90133-1
   PubMed Web of Science ®Google Scholar
• Skarnes WC, Rosen B, West AP, et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature. 2011;474(7351):337–342. InternetAvailable from. doi: 10.1038/nature10163
   PubMed Web of Science ®Google Scholar
• Chew TS, O’Shea NR, Sewell GW, et al. Optineurin deficiency in mice contributes to impaired cytokine secretion and neutrophil recruitment in bacteria-driven colitis. Dis Model Mech. 2015;8:817–829. InternetAvailable from: doi: 10.1242/dmm.020362
   PubMed Web of Science ®Google Scholar
• Heuser M, Argiropoulos B, Kuchenbauer F, et al. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. Blood. 2007;110(5):1639–1647. doi: 10.1182/blood-2007-03-080523
   PubMed Web of Science ®Google Scholar
• Wai T, Langer T. Mitochondrial dynamics and metabolic regulation. Trends Endocrinol Metab. 2016;27:105–117. InternetAvailable from. doi: 10.1016/j.tem.2015.12.001
   PubMed Web of Science ®Google Scholar
• Twig G, Elorza A, Molina AJA, et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. Embo J. 2008;27(2):433–446. doi: 10.1038/sj.emboj.7601963
   PubMed Web of Science ®Google Scholar
• Georgakopoulos ND, Wells G, Campanella M. The pharmacological regulation of cellular mitophagy. Nat Chem Biol. 2017;13(2):136–146. doi: 10.1038/nchembio.2287 InternetAvailable from.
   PubMed Web of Science ®Google Scholar
• The Cancer Genome Atlas Research Network . Genomic and epigenomic landscapes of adult de novo acute myeloid Leukemia. N Engl J Med. 2013;368(22):2059–2074. doi: 10.1056/NEJMoa1301689
   PubMed Web of Science ®Google Scholar
• Rodrigues T, Ferraz LS. Therapeutic potential of targeting mitochondrial dynamics in cancer. Biochem Pharmacol. 2020;182:114282. InternetAvailable from. doi: 10.1016/j.bcp.2020.114282
   PubMed Web of Science ®Google Scholar
• Morita K, Hama Y, Izume T, et al. Genome-wide CRISPR screen identifies TMEM41B as a gene required for autophagosome formation. J Cell Bio. 2018;217(11):3817–3828. doi: 10.1083/jcb.201804132
   PubMed Web of Science ®Google Scholar
• Heo JM, Harper NJ, Paulo JA, et al. Integrated proteogenetic analysis reveals the landscape of a mitochondrial-autophagosome synapse during PARK2-dependent mitophagy. Sci Adv. 2019;5(11): doi: 10.1126/sciadv.aay4624
   Web of Science ®Google Scholar
• Hoshino A, Wang WJ, Wada S, et al. The ADP/ATP translocase drives mitophagy independent of nucleotide exchange. Nature. 2019;575(7782):375–379. doi: 10.1038/s41586-019-1667-4
   PubMed Web of Science ®Google Scholar
• van Humbeeck C, Cornelissen T, Hofkens H, et al. Parkin interacts with ambra1 to induce mitophagy. J Neurosci. 2011;31(28):10249–10261. doi: 10.1523/JNEUROSCI.1917-11.2011
   PubMed Web of Science ®Google Scholar
• Chu CT, Ji J, Dagda RK, et al. Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat Cell Biol. 2013;15(10):1197–1205 doi: 10.1038/ncb2837. InternetAvailable from:
   PubMed Web of Science ®Google Scholar
• Princely Abudu Y, Pankiv S, Mathai BJ, et al. NIPSNAP1 and NIPSNAP2 act as “Eat Me” sgnals for mitophagy. Dev Cell. 2019;49(4):509–525.e12. doi: 10.1016/j.devcel.2019.03.013
   PubMed Web of Science ®Google Scholar
• Moore AS, Holzbaur ELF. Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy. Proc Natl Acad Sci. 2016;113(24):E3349–E3358. InternetAvailable from. doi: 10.1073/pnas.1523810113
   PubMed Web of Science ®Google Scholar
• Qiu Y, Wang J, Li H, et al. Emerging views of OPTN (optineurin) function in the autophagic process associated with disease. Autophagy. 2021;18(1):73–85. InternetAvailable from. doi: 10.1080/15548627.2021.1908722
   PubMed Web of Science ®Google Scholar
• Bansal M, Moharir SC, Sailasree SP, et al. Optineurin promotes autophagosome formation by recruiting the autophagy-related Atg12-5-16L1 complex to phagophores containing the Wipi2 protein. J Biol Chem. 2018;293(1):132–147. doi: 10.1074/jbc.M117.801944
   PubMed Web of Science ®Google Scholar
• Chen K, Dai H, Yuan J, et al. Optineurin-mediated mitophagy protects renal tubular epithelial cells against accelerated senescence in diabetic nephropathy article. Cell Death Dis. 2018;9(2):1–18. InternetAvailable from. doi: 10.1038/s41419-017-0127-z
   PubMed Web of Science ®Google Scholar
• Heo JM, Ordureau A, Paulo JA, et al. The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol Cell. 2015;60(1):7–20. InternetAvailable from. doi: 10.1016/j.molcel.2015.08.016
   PubMed Web of Science ®Google Scholar
• Sumitomo Y, Koya J, Nakazaki K, et al. Cytoprotective autophagy maintains leukemia-initiating cells in murine myeloid leukemia. Blood. 2016;128(12):1614–1624. doi: 10.1182/blood-2015-12-684696
   PubMed Web of Science ®Google Scholar
• Qu X, Yu J, Bhagat G, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest. 2003;112(12):1809–1820. doi: 10.1172/JCI20039
   PubMed Web of Science ®Google Scholar
• Panina SB, Pei J, Kirienko NV. Mitochondrial metabolism as a target for acute myeloid leukemia treatment. Cancer Metab. 2021;9(1):1–25. doi: 10.1186/s40170-021-00253-w
   PubMed Web of Science ®Google Scholar
• Ryan TA, Tumbarello DA. Optineurin: a coordinator of membrane-associated cargo trafficking and autophagy. Front Immunol. 2018;9:1–16. InternetAvailable from: doi: 10.3389/fimmu.2018.01024/full
   PubMed Web of Science ®Google Scholar
• Liu Z, Chen P, Gao H, et al. Ubiquitylation of autophagy receptor optineurin by HACE1 activates selective autophagy for tumor suppression. Cancer Cell. 2014;26(1):106–120. doi: 10.1016/j.ccr.2014.05.015
   PubMed Web of Science ®Google Scholar
• Rodrigo R, Mendis N, Ibrahim M, et al. Knockdown of BNIP3L or SQSTM1 alters cellular response to mitochondria target drugs. Autophagy. 2019;15(5):900–907. InternetAvailable from. doi: 10.1080/15548627.2018.1558002
   PubMed Web of Science ®Google Scholar
• Li Y, Li Y, Yin J, et al. A mitophagy inhibitor targeting p62 attenuates the leukemia-initiation potential of acute myeloid leukemia cells. Cancer Lett [InternetAvailable from]. 2021;510:24–36. doi: 10.1016/j.canlet.2021.04.003
   PubMed Web of Science ®Google Scholar
• Palikaras K, Lionaki E, Tavernarakis N. Balancing mitochondrial biogenesis and mitophagy to maintain energy metabolism homeostasis. Cell Death Differ. 2015;22(9):1399–1401. doi: 10.1038/cdd.2015.86
   PubMed Web of Science ®Google Scholar
• Ito K, Turcotte R, Cui J, et al. Self-renewal of a purified Tie2 + hematopoietic stem cell population relies on mitochondrial clearance. Science. 2016;354(6316):1156–1160. doi: 10.1126/science.aaf5530
   PubMed Web of Science ®Google Scholar
• Sriskanthadevan S, Jeyaraju DV, Chung TE, et al. AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress. Blood. 2015;125(13):2120–2130. doi: 10.1182/blood-2014-08-594408
   PubMed Web of Science ®Google Scholar
• Slowicka K, Vereecke L, van Loo G. Cellular functions of Optineurin in health and disease. Trends Immunol. 2016;37:621–633. InternetAvailable from. doi: 10.1016/j.it.2016.07.002
   PubMed Web of Science ®Google Scholar
• Rezaie T, Child A, Hitchings R, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science. 2002;295(5557):1077–1079. doi: 10.1126/science.1066901
   PubMed Web of Science ®Google Scholar
• Sperling AS, Gibson CJ, Ebert BL. The genetics of myelodysplastic syndrome: from clonal hematopoiesis to secondary leukemia. Nat Rev Cancer. 2017;17(1):5–19. doi: 10.1038/nrc.2016.112
   PubMed Web of Science ®Google Scholar
• Aoyagi Y, Hayashi Y, Harada Y, et al. Mitochondrial fragmentation triggers ineffective hematopoiesis in myelodysplastic syndromes. Cancer Discov. 2022;12(1):250–269. InternetAvailable from: https://aacrjournals.org/cancerdiscovery/article/12/1/250/675593/Mitochondrial-Fragmentation-Triggers-Ineffective
   PubMed Web of Science ®Google Scholar
• Teramachi J, Myint KZY, Feng R, et al. Blocking the ZZ domain of sequestosome 1/p62 suppress the enhancement of myeloma cell growth and osteoclast formation by marrow stromal cells. Blood. 2011;118(21):888–888. InternetAvailable from. doi: 10.1182/blood.V118.21.888.888
   Web of Science ®Google Scholar
• Silbermann R, Zhou D, Teramachi J, et al. The p62-ZZ domain inhibitor XRK3F2 alters myeloma-induced suppression of osteoblast differentiation and is highly cytotoxic to myeloma cells in combination with Bortezomib. Blood. 2014;124(21):2083–2083. InternetAvailable from. doi: 10.1182/blood.V124.21.2083.2083
   Web of Science ®Google Scholar
• Zhang L, Fang Y, Cheng X, et al. Interaction between TRPML1 and p62 in regulating autophagosome-lysosome fusion and impeding neuroaxonal dystrophy in Alzheimer’s disease. In: Lloret A, editor. Oxid med cell longev; 2022. p. 1–20. Available from: https://www.hindawi.com/journals/omcl/2022/8096009/
   Google Scholar
• Dai W, Wang G, Chwa J, et al. Mitochondrial division inhibitor (mdivi-1) decreases oxidative metabolism in cancer. Br J Cancer. 2020;122(9):1288–1297. InternetAvailable from. doi: 10.1038/s41416-020-0778-x
   PubMed Web of Science ®Google Scholar
• Peiris-Pagès M, Bonuccelli G, Sotgia F, et al. Mitochondrial fission as a driver of stemness in tumor cells: mDIVI1 inhibits mitochondrial function, cell migration and cancer stem cell (CSC) signalling. Oncotarget. 2018;9(17):13254–13275. doi: 10.18632/oncotarget.24285
   PubMedGoogle Scholar
• Wegner M, Diehl V, Bittl V, et al. Circular synthesized CRISPR/Cas gRnas for functional interrogations in the coding and noncoding genome. Elife. 2019;8:1–31. doi: 10.7554/eLife.42549
   Web of Science ®Google Scholar
• Li W, Xu H, Xiao T, et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol. 2014;15(12):554. doi: 10.1186/s13059-014-0554-4
   PubMed Web of Science ®Google Scholar
• Najm FJ, Strand C, Donovan KF, et al. Orthologous CRISPR–Cas9 enzymes for combinatorial genetic screens. Nat Biotechnol. 2018;36(2):179–189. InternetAvailable from. doi: 10.1038/nbt.4048
   PubMed Web of Science ®Google Scholar
• Baker F, Polat IH, Abou‐el‐Ardat K, et al. Metabolic rewiring is essential for AML cell survival to overcome autophagy inhibition by loss of ATG3. Cancers (Basel). 2021;13(23):1–19. doi: 10.3390/cancers13236142
   Web of Science ®Google Scholar